Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Ultrasound Assessment of Kidneys From Donation After Brain Death (DBD) to Predict the Risk Model of Early Postoperative Renal Insufficiency in Renal Transplantation

NCT07090512 is registered in ClinicalTrials.gov with Bei Wang as lead sponsor.

NCT NCT07090512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Ultrasound Assessment of Kidneys From Donation After Brain Death (DBD) to Predict the Risk Model of Early Postoperative Renal Insufficiency in Renal Transplantation
Lead sponsor
Bei Wang
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
March 31, 2026
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

occurrence of renal dysfunction (gfr ≤ 60ml/(min·1.73m2)) in renal transplant recipients within one year after kidney transplantation